Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ilaria Leccese
'Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation’ by Braaten Et Al: Another Point of View
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Prediction of Chronic Damage in Systemic Lupus Erythematosus by Using Machine-Learning Models
PLoS ONE
Multidisciplinary
Related publications
Immune Checkpoint Inhibitor-Induced Fanconi Syndrome
Cureus
Another Point of View
Science
Multidisciplinary
Philosophy of Science
History
Response to Comment on Trinh Et Al. Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153–e154
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Characteristics and Treatment of New-Onset Arthritis After Checkpoint Inhibitor Therapy
RMD Open
Rheumatology
Allergy
Immunology
Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review
Internal Medicine
Internal Medicine
Medicine
Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020
Kidney360
In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk
Mayo Clinic Proceedings
Medicine
Loss of Fas Expression and Function Is Coupled With Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Systemic Immunotherapy of Superficial Mouse Bladder Cancer With Avelumab (MSB0010718C), an Anti-Pd-L1 Immune Checkpoint Inhibitor
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
